Found 8 matching trials
Prognostic Value of KELIM Score and Inflammatory Markers in Ovarian Cancer N/A This is a retrospective observational study to evaluate the integrative pro...
Show More Status
Active Not Recruiting
Location
Sohag university hospital
Learn More & Join Trial
Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer PHASE2 About 70% of epithelial ovarian cancer patients are diagnosed at advanced s...
Show More Location
The University of Hong Kong
Learn More & Join Trial
Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery PHASE3 SALVOVAR will be a pragmatic open-label multicenter randomized phase III tr...
Show More Learn More & Join Trial
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer PHASE2 About 70% of epithelial ovarian cancer patients are diagnosed at advanced s...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Longitudinal Plasma Proteomic Remodeling in Ovarian Cancer NA This longitudinal observational study investigates treatment-associated cha...
Show More Learn More & Join Trial
NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery NA A prospective, international, multi-center, interventional trial of advance...
Show More Location
Multiple Locations
Learn More & Join Trial
Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer N/A This study aims to understand whether it is possible to predict the effecti...
Show More Learn More & Join Trial
Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer PHASE1 The purpose of this clinical trial is to assess the safety and efficacy of ...
Show More Location
Institut Bergonié
Learn More & Join Trial